Author: Mindy Hermann, MBA, RDN

Mindy Hermann, MBA, RDN, is a food and beverage communications consultant based in metro New York.

The newest generation of antiobesity medications (AOMs)—GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), dual action GLP-1/GIP combinations, triple action injectables, and emerging injectable and oral medications—have changed the landscape for weight management, bringing weight loss success to many for whom weight maintenance had previously not been possible.

Today’s Dietitian explores the complexities of the immune system and the latest research on the role nutrition plays in boosting immune health in seniors and the products on the market that claim to help.

As concerns about climate change and sustainability increase, science is generating new, innovative, and environmentally conscious ways for consumers to enjoy alternative seafood options made to resemble and taste like the real thing.